The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cognitive Behavioral Therapy for Insomnia Market Research Report 2024
Synopsis
Global Cognitive Behavioral Therapy for Insomnia market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cognitive Behavioral Therapy for Insomnia market research.
Key companies engaged in the Cognitive Behavioral Therapy for Insomnia industry include MINERVA NEUROSCIENCES INC, CURRAX PHARMACEUTICALS LLC, Pfizer Inc., Sanofi, zydus cadila, Vanda Pharmaceuticals Inc., EISAI,, merck kgaa and darmstadt, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cognitive Behavioral Therapy for Insomnia were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cognitive Behavioral Therapy for Insomnia market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cognitive Behavioral Therapy for Insomnia market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
MINERVA NEUROSCIENCES INC
CURRAX PHARMACEUTICALS LLC
Pfizer Inc.
Sanofi
zydus cadila
Vanda Pharmaceuticals Inc.
EISAI,
merck kgaa
darmstadt
germany
VIATRIS INC
Takeda Pharmaceutical Company
Segment by Type
Non Pharmacological Therapy
Pharmacological Therapy
Segment by Application
Mental Health Services
Sleep Clinics
Pharmaceutical Industry
Sleep-related Devices and Technology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cognitive Behavioral Therapy for Insomnia report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Global Cognitive Behavioral Therapy for Insomnia market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cognitive Behavioral Therapy for Insomnia market research.
Key companies engaged in the Cognitive Behavioral Therapy for Insomnia industry include MINERVA NEUROSCIENCES INC, CURRAX PHARMACEUTICALS LLC, Pfizer Inc., Sanofi, zydus cadila, Vanda Pharmaceuticals Inc., EISAI,, merck kgaa and darmstadt, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cognitive Behavioral Therapy for Insomnia were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cognitive Behavioral Therapy for Insomnia market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cognitive Behavioral Therapy for Insomnia market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
MINERVA NEUROSCIENCES INC
CURRAX PHARMACEUTICALS LLC
Pfizer Inc.
Sanofi
zydus cadila
Vanda Pharmaceuticals Inc.
EISAI,
merck kgaa
darmstadt
germany
VIATRIS INC
Takeda Pharmaceutical Company
Segment by Type
Non Pharmacological Therapy
Pharmacological Therapy
Segment by Application
Mental Health Services
Sleep Clinics
Pharmaceutical Industry
Sleep-related Devices and Technology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cognitive Behavioral Therapy for Insomnia report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cognitive Behavioral Therapy for Insomnia Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Non Pharmacological Therapy
1.2.3 Pharmacological Therapy
1.3 Market by Application
1.3.1 Global Cognitive Behavioral Therapy for Insomnia Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Mental Health Services
1.3.3 Sleep Clinics
1.3.4 Pharmaceutical Industry
1.3.5 Sleep-related Devices and Technology
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cognitive Behavioral Therapy for Insomnia Market Perspective (2018-2029)
2.2 Cognitive Behavioral Therapy for Insomnia Growth Trends by Region
2.2.1 Global Cognitive Behavioral Therapy for Insomnia Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cognitive Behavioral Therapy for Insomnia Historic Market Size by Region (2018-2023)
2.2.3 Cognitive Behavioral Therapy for Insomnia Forecasted Market Size by Region (2024-2029)
2.3 Cognitive Behavioral Therapy for Insomnia Market Dynamics
2.3.1 Cognitive Behavioral Therapy for Insomnia Industry Trends
2.3.2 Cognitive Behavioral Therapy for Insomnia Market Drivers
2.3.3 Cognitive Behavioral Therapy for Insomnia Market Challenges
2.3.4 Cognitive Behavioral Therapy for Insomnia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cognitive Behavioral Therapy for Insomnia Players by Revenue
3.1.1 Global Top Cognitive Behavioral Therapy for Insomnia Players by Revenue (2018-2023)
3.1.2 Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Players (2018-2023)
3.2 Global Cognitive Behavioral Therapy for Insomnia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cognitive Behavioral Therapy for Insomnia Revenue
3.4 Global Cognitive Behavioral Therapy for Insomnia Market Concentration Ratio
3.4.1 Global Cognitive Behavioral Therapy for Insomnia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cognitive Behavioral Therapy for Insomnia Revenue in 2022
3.5 Cognitive Behavioral Therapy for Insomnia Key Players Head office and Area Served
3.6 Key Players Cognitive Behavioral Therapy for Insomnia Product Solution and Service
3.7 Date of Enter into Cognitive Behavioral Therapy for Insomnia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cognitive Behavioral Therapy for Insomnia Breakdown Data by Type
4.1 Global Cognitive Behavioral Therapy for Insomnia Historic Market Size by Type (2018-2023)
4.2 Global Cognitive Behavioral Therapy for Insomnia Forecasted Market Size by Type (2024-2029)
5 Cognitive Behavioral Therapy for Insomnia Breakdown Data by Application
5.1 Global Cognitive Behavioral Therapy for Insomnia Historic Market Size by Application (2018-2023)
5.2 Global Cognitive Behavioral Therapy for Insomnia Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cognitive Behavioral Therapy for Insomnia Market Size (2018-2029)
6.2 North America Cognitive Behavioral Therapy for Insomnia Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cognitive Behavioral Therapy for Insomnia Market Size by Country (2018-2023)
6.4 North America Cognitive Behavioral Therapy for Insomnia Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cognitive Behavioral Therapy for Insomnia Market Size (2018-2029)
7.2 Europe Cognitive Behavioral Therapy for Insomnia Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cognitive Behavioral Therapy for Insomnia Market Size by Country (2018-2023)
7.4 Europe Cognitive Behavioral Therapy for Insomnia Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size (2018-2029)
8.2 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size by Region (2018-2023)
8.4 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cognitive Behavioral Therapy for Insomnia Market Size (2018-2029)
9.2 Latin America Cognitive Behavioral Therapy for Insomnia Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cognitive Behavioral Therapy for Insomnia Market Size by Country (2018-2023)
9.4 Latin America Cognitive Behavioral Therapy for Insomnia Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Size (2018-2029)
10.2 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Size by Country (2018-2023)
10.4 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MINERVA NEUROSCIENCES INC
11.1.1 MINERVA NEUROSCIENCES INC Company Detail
11.1.2 MINERVA NEUROSCIENCES INC Business Overview
11.1.3 MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Introduction
11.1.4 MINERVA NEUROSCIENCES INC Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.1.5 MINERVA NEUROSCIENCES INC Recent Development
11.2 CURRAX PHARMACEUTICALS LLC
11.2.1 CURRAX PHARMACEUTICALS LLC Company Detail
11.2.2 CURRAX PHARMACEUTICALS LLC Business Overview
11.2.3 CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Introduction
11.2.4 CURRAX PHARMACEUTICALS LLC Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.2.5 CURRAX PHARMACEUTICALS LLC Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Detail
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Introduction
11.3.4 Pfizer Inc. Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.3.5 Pfizer Inc. Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Cognitive Behavioral Therapy for Insomnia Introduction
11.4.4 Sanofi Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.4.5 Sanofi Recent Development
11.5 zydus cadila
11.5.1 zydus cadila Company Detail
11.5.2 zydus cadila Business Overview
11.5.3 zydus cadila Cognitive Behavioral Therapy for Insomnia Introduction
11.5.4 zydus cadila Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.5.5 zydus cadila Recent Development
11.6 Vanda Pharmaceuticals Inc.
11.6.1 Vanda Pharmaceuticals Inc. Company Detail
11.6.2 Vanda Pharmaceuticals Inc. Business Overview
11.6.3 Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Introduction
11.6.4 Vanda Pharmaceuticals Inc. Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.6.5 Vanda Pharmaceuticals Inc. Recent Development
11.7 EISAI,
11.7.1 EISAI, Company Detail
11.7.2 EISAI, Business Overview
11.7.3 EISAI, Cognitive Behavioral Therapy for Insomnia Introduction
11.7.4 EISAI, Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.7.5 EISAI, Recent Development
11.8 merck kgaa
11.8.1 merck kgaa Company Detail
11.8.2 merck kgaa Business Overview
11.8.3 merck kgaa Cognitive Behavioral Therapy for Insomnia Introduction
11.8.4 merck kgaa Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.8.5 merck kgaa Recent Development
11.9 darmstadt
11.9.1 darmstadt Company Detail
11.9.2 darmstadt Business Overview
11.9.3 darmstadt Cognitive Behavioral Therapy for Insomnia Introduction
11.9.4 darmstadt Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.9.5 darmstadt Recent Development
11.10 germany
11.10.1 germany Company Detail
11.10.2 germany Business Overview
11.10.3 germany Cognitive Behavioral Therapy for Insomnia Introduction
11.10.4 germany Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.10.5 germany Recent Development
11.11 VIATRIS INC
11.11.1 VIATRIS INC Company Detail
11.11.2 VIATRIS INC Business Overview
11.11.3 VIATRIS INC Cognitive Behavioral Therapy for Insomnia Introduction
11.11.4 VIATRIS INC Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.11.5 VIATRIS INC Recent Development
11.12 Takeda Pharmaceutical Company
11.12.1 Takeda Pharmaceutical Company Company Detail
11.12.2 Takeda Pharmaceutical Company Business Overview
11.12.3 Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Introduction
11.12.4 Takeda Pharmaceutical Company Revenue in Cognitive Behavioral Therapy for Insomnia Business (2018-2023)
11.12.5 Takeda Pharmaceutical Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
